Figure 5.
DDAVP reduction of ADAMTS13 is mediated via the V2-receptor signaling. Using a V2-selective receptor antagonist (tolvaptan, 50 nmol/L) prevented DDAVP-induced reduction of ADAMTS13 transcripts in endothelial cells after 24 h of incubation.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.